Hundreds of drugs are approved in the U.S. every year, but GoodRx recently listed one dozen approvals that it said were the most influential for 2023.
The report by GoodRx, a digital pharmaceutical platform, highlighted drugs that it said represented a major advancement compared to other treatment options.
The new list came as the U.S. public has been hearing a lot about weight-loss drugs such as Ozempic and Wegovy; and a new drug in that category, Zepbound, is included on the GoodRx list. However, the list includes a wide range of drugs and vaccines, including a contraceptive, treatments for respiratory diseases, and a treatment for Alzheimer's disease.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
